Embryos Right Genetic Wrongs?

New evidence supports an old idea that embryos with genetic abnormalities can somehow fix themselves early in development.

Written byAmy Maxmen
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

THE CENTER FOR PREIMPLANTATION GENETICS, LABCORP

Embryos whose cells acquire too many or too few chromosomes have a diminished chance of surviving to full term. If they do survive, the abnormal count could result in Down syndrome or another chromosomal disorder. But some of these defective embryos can actually fix their genetic mistakes, according to a study reported last week at the European Society of Human Reproduction and Embryology meeting in Stockholm, Sweden.

The idea was originally proposed in the 1990s, but with little evidence and a lot of skepticism, had quickly fallen by the wayside. The new study garners support for this controversial concept that, if true, is certain to impact patients and doctors involved in the infertility treatment, in vitro fertilization (IVF).

"I think this is an important phenomenon ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies